Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

  • This share is currently suspended. It was suspended at a price of 28.58

Share Price Information for Ferrexpo (FXPO)

Share Price is delayed by 15 minutes
Get Live Data
28.58    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £168.16m
FXPO Live PriceLast checked at - London Stock Exchange

Intraday Ferrexpo Share Chart

New Debt Facility

4 Dec 2009 07:00

RNS Number : 5790D
Ferrexpo PLC
04 December 2009
 



4 December 2009

Ferrexpo plc

("Ferrexpo" or "the Company")

 

New Debt Facility

Ferrexpo is pleased to announce that it has secured a new Pre-Export Financing ("PXF") facility in an amount of US$230 million (the "Loan"). 

This transaction is the first successful financing to be concluded by a metals and mining company with assets located in the CIS since the global financial crisis began in September 2008. 

Deutsche Bank AG acted as Coordinator, Mandated Lead Arranger and Bookrunner for the Loan and provided funding, together with 10 other prominent financial institutions, including:

WestLB AG, London Branch

J.P. Morgan plc

BNP Paribas (Suisse) SA

UBS Investment Bank

Fortis Bank (Nederland) N.V.

Stichting Pensioenfonds Zorg en Welzijn

Natixis

CALYON

Raiffeisen Zentralbank Österreich AG

VTB Bank (France) SA

The Loan will be available for drawdown from 1 January 2010, and will be used for financing and general corporate purposes. The Loan matures 36 months from 1 January 2010 and is to be repaid in 24 equal monthly instalments with the first instalment falling due in January 2011. The margin of the Loan is 7.00% above US dollar LIBOR.

Kris Van BroekhovenDeutsche Bank's Head of Structured Commodity and Trade Finance for EMEA, said:

"Deutsche Bank is pleased to have been able to assist Ferrexpo in this debt financing. Ferrexpo's strong performance in the downturn, its business record and commitment to best practice make it an attractive customer to international financial institutions."

Chris MaweChief Financial Officer of Ferrexpo, said:

"Ferrexpo is pleased to have successfully renewed its debt facilities despite extremely challenging debt market conditions. The Company's ability to attract financing from both existing and new lenders is testament to the strength of its relationships with many of the world's leading banks. This is as a result of its commitment to transparency and best practice corporate governance, the Company's strong fundamentals, its financial performance over the past twelve months and the ongoing resilience of its business model. The new PXF will provide Ferrexpo with the necessary financial flexibility to invest the cash flow generated by its existing business in the development of its world class iron ore resources."

For further information, please contact:

Ferrexpo: +44 20 7389 8304

Gavin Mackay

Pelham: +44 20 7337 1500

Charles Vivian

Evgeniy Chuikov

Notes to Editors:

Ferrexpo is a Swiss headquartered resources company with assets in Ukraine, principally involved in the production and export of iron ore pellets, used in producing steel. Current output is over 9 million tonnes, most of which is exported to steelmakers around the world. The Group is listed on the main market of the London Stock Exchange under the ticker FXPO. For further information please visit www.ferrexpo.com. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPADEFKNFFE
Date   Source Headline
29th May 20267:00 amRNSNotice of 2026 Annual General Meeting
28th Apr 20267:00 amRNSFunding Update and Delay in Financial Statements
22nd Apr 20267:00 amRNSUpdate on funding options
20th Apr 20267:00 amRNSSale of Iron Destiny and Update on Funding Options
15th Apr 20267:00 amRNSProduction Report for 1Q 2026
1st Apr 20269:41 amRNSTrading Update
9th Mar 20267:00 amRNSOperations and Corporate Update
2nd Mar 20268:20 amRNSDirector/PDMR Shareholding
24th Feb 20263:35 pmRNSUpdate regarding Ukrainian subsidiary
20th Jan 20263:39 pmRNSUpdate on operations in Ukraine
14th Jan 20267:00 amRNSProduction Report for 4Q 2025
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
14th Nov 20257:05 amRNSDirector Declaration
10th Nov 20257:00 amRNSLimited attack on power infrastructure
4th Nov 20257:00 amRNSPublication of Responsible Business Report
6th Oct 20257:00 amRNSProduction Report for 3Q 2025
11th Sep 202511:59 amRNSGeneral Meeting voting results
11th Aug 20257:00 amRNSPublication of Notice of General Meeting 2025
6th Aug 20257:00 amRNSInterim Results for six months ended 30 June 2025
7th Jul 20257:00 amRNSProduction Report for 2Q 2025
10th Jun 20254:48 pmRNSDirector/PDMR Shareholding
9th Jun 20254:35 pmRNSDirector/PDMR Shareholding
22nd May 202512:47 pmRNSResult of AGM
16th May 20255:00 pmRNSReport on Payments to Governments
15th May 202512:15 pmRNSUpdate regarding Ukrainian subsidiary
30th Apr 20257:00 amRNSLetter to shareholders re: auditor engagement
17th Apr 20255:32 pmRNSUkraine subsidiaries VAT refunds
10th Apr 20257:00 amRNSNotice of Annual General Meeting and 2024 ARA
7th Apr 20257:00 amRNSProduction Report for 1Q 2025
21st Mar 20257:00 amRNSStatement regarding Ukraine VAT refunds
19th Mar 20258:00 amRNSInternational Investment Agreements Notification
19th Mar 20257:00 amRNSFull Year Financial Results for 2024
11th Mar 20257:00 amRNSAnnouncement of Full Year 2024 Financial Results
5th Mar 20257:00 amRNSResponse to SBI Statement
4th Feb 20253:17 pmRNSUpdate regarding Ukrainian subsidiary
23rd Jan 20259:52 amRNSUpdate regarding Ukrainian Subsidiary
16th Jan 202511:30 amRNSUpdate regarding Ukrainian subsidiary
13th Jan 20257:00 amRNSResignation of Non-Executive Director
9th Jan 20257:00 amRNSProduction Report for 4Q 2024
30th Dec 20245:00 pmRNSPublication of Responsible Business Report
30th Dec 20245:00 pmRNSPublication of Climate Change Report
7th Oct 20247:00 amRNSProduction Report for 3Q 2024
19th Sep 202412:31 pmRNSGeneral Meeting voting results
12th Aug 20247:00 amRNSNotice of General Meeting 2024
5th Aug 20244:50 pmRNSUpdate on restrictions on shares in subsidiary
31st Jul 202412:28 pmRNSInterim Results for six months ended 30 June 2024
31st Jul 20247:00 amRNSInterim Results for six months ended 30 June 2024
30th Jul 20245:50 pmRNSInterim Results Advisory
8th Jul 20247:00 amRNSProduction Report for 2Q 2024 and 1H 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.